- Home
- ETON vs DIN Comparison
ETON vs DIN Comparison
Compare ETON & DIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- DIN
- Stock Information
- Founded
- ETON 2017
- DIN 1958
- Country
- ETON United States
- DIN United States
- Employees
- ETON N/A
- DIN N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- DIN Restaurants
- Sector
- ETON Health Care
- DIN Consumer Discretionary
- Exchange
- ETON Nasdaq
- DIN Nasdaq
- Market Cap
- ETON 428.5M
- DIN 311.3M
- IPO Year
- ETON 2018
- DIN 1991
- Fundamental
- Price
- ETON $17.14
- DIN $22.24
- Analyst Decision
- ETON Strong Buy
- DIN Hold
- Analyst Count
- ETON 3
- DIN 8
- Target Price
- ETON $27.67
- DIN $26.33
- AVG Volume (30 Days)
- ETON 221.4K
- DIN 618.1K
- Earning Date
- ETON 05-13-2025
- DIN 05-07-2025
- Dividend Yield
- ETON N/A
- DIN 9.04%
- EPS Growth
- ETON N/A
- DIN N/A
- EPS
- ETON N/A
- DIN 3.61
- Revenue
- ETON $39,011,000.00
- DIN $820,851,000.00
- Revenue This Year
- ETON $92.33
- DIN $7.80
- Revenue Next Year
- ETON $52.62
- DIN $1.71
- P/E Ratio
- ETON N/A
- DIN $6.25
- Revenue Growth
- ETON 23.29
- DIN N/A
- 52 Week Low
- ETON $3.18
- DIN $18.63
- 52 Week High
- ETON $18.41
- DIN $45.69
- Technical
- Relative Strength Index (RSI)
- ETON 70.21
- DIN 60.52
- Support Level
- ETON $16.43
- DIN $19.52
- Resistance Level
- ETON $17.49
- DIN $20.87
- Average True Range (ATR)
- ETON 0.85
- DIN 0.91
- MACD
- ETON 0.18
- DIN 0.44
- Stochastic Oscillator
- ETON 98.09
- DIN 96.12
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About DIN Dine Brands Global Inc.
Dine Brands Global Inc owns and franchises thousands of restaurants under the Applebee's and International House of Pancakes names. Almost all company restaurants are located in the United States and franchised. Royalty revenue, which the company gets from franchisees based on franchisees' sales, accounts for roughly three-quarters of total company revenue. The company also earns revenue by leasing restaurant sites to franchisees. The company has four reportable segments Franchise operations, (an aggregation of Applebee's and IHOP franchise operations), Rental operations, Financing operations and Company-operated restaurant operations. The majority of revenue is derived from the Franchise operations segment.